MINNEAPOLIS & BOSTON--(BUSINESS WIRE)--Fluid monitoring with OptiVol® Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart ...

Mode Sensors has gained US Food and Drug Administration (FDA) clearance for Re:Balans, a fluid monitoring wearable, setting the stage for the sensor’s commercialisation in US clinical wards. With FDA ...

The BodiGuide System includes the first wearable device specifically designed to replace weight scales and pitting edema tests in the management of heart failure. This new patented system continuously ...

The use of intrathoracic impedance monitoring is more accurate in predicting worsening HF than daily weight monitoring in patients with HF indicated for implantation of a cardiac resynchronization ...

Pulmonary congestion is the main reason for > 90% of hospital admissions for worsening heart failure (HF) in the United States, and now this problem has been addressed by the development of an ...

OSLO, Norway, October 22, 2025--(BUSINESS WIRE)--Mode Sensors (www.modesensors.com) announced today that its Re:Balans hydration monitoring system has received 510(k) clearance from the U.S. Food and ...

The Bodyport Cardiac Scale is designed to detect signals through an individual’s feet to noninvasively measure a broad spectrum of hemodynamic biomarkers for heart function and fluid status. The Food ...

LONDON, UK — Patients with heart failure who had a device that alerted physicians when it detected that fluid in the chest was above a certain threshold did not have fewer CV hospitalizations or ...